Ensign Peak Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-74,760
| Closed | -$323K | – | 1763 |
|
|
2023
Q3 | $323K | Hold |
74,760
| – | – | ﹤0.01% | 1679 |
|
|
2023
Q2 | $493K | Hold |
74,760
| – | – | ﹤0.01% | 1637 |
|
|
2023
Q1 | $508K | Buy |
74,760
+21,800
| +41% | +$148K | ﹤0.01% | 1640 |
|
|
2022
Q4 | $391K | Buy |
52,960
+22,800
| +76% | +$168K | ﹤0.01% | 1673 |
|
|
2022
Q3 | $298K | Hold |
30,160
| – | – | ﹤0.01% | 1708 |
|
|
2022
Q2 | $329K | Hold |
30,160
| – | – | ﹤0.01% | 1637 |
|
|
2022
Q1 | $341K | Hold |
30,160
| – | – | ﹤0.01% | 1709 |
|
|
2021
Q4 | $473K | Sell |
30,160
-23,140
| -43% | -$363K | ﹤0.01% | 1649 |
|
|
2021
Q3 | $914K | Hold |
53,300
| – | – | ﹤0.01% | 1465 |
|
|
2021
Q2 | $1.15M | Hold |
53,300
| – | – | ﹤0.01% | 1391 |
|
|
2021
Q1 | $801K | Hold |
53,300
| – | – | ﹤0.01% | 1490 |
|
|
2020
Q4 | $700K | Hold |
53,300
| – | – | ﹤0.01% | 1522 |
|
|
2020
Q3 | $515K | Hold |
53,300
| – | – | ﹤0.01% | 1525 |
|
|
2020
Q2 | $610K | Hold |
53,300
| – | – | ﹤0.01% | 1418 |
|
|
2020
Q1 | $552K | Buy |
53,300
+6,500
| +14% | +$67.3K | ﹤0.01% | 1370 |
|
|
2019
Q4 | $768K | Buy |
+46,800
| New | +$768K | ﹤0.01% | 1419 |
|